FDA Approves AirDuo Digihaler (fluticasone propionate and salmeterol) Inhalation Powder for Asthma

JERUSALEM and PARSIPPANY, N.J., July 15, 2019– Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved AirDuo® Digihaler™ (fluticasone propionate 113...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news